The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
MicroRNA regulates human vitamin D receptor
Open accessAbstract
Most of the biological effects of 1α,25‐dihydroxyvitamin D 3 (1,25(OH)2 D 3) are elicited by the binding to vitamin D receptor (VDR), which regulates gene expression. Earlier studies reported no correlation between the VDR protein and mRNA levels, suggesting the involvement of posttranscriptional regulation. MicroRNAs (miRNAs) are small noncoding RNAs that regulate gene expression through translational repression or mRNA degradation. A potential miR‐125b recognition element (MRE125b) was identified in the 3′‐untranslated region of human VDR mRNA. We investigated whether VDR is regulated by miR‐125b. In luciferase assays using a plasmid containing the MRE125b, the antisense oligonucleotide for miR‐125b significantly increased (130% of control) the reporter activity in KGN cells, whereas the precursor for miR‐125b significantly decreased (40% of control) the reporter activity in MCF‐7 cells, suggesting that miR‐125b functionally recognized the MRE125b. By electrophoretic mobility shift assays, it was demonstrated that the overexpression of miR‐125b significantly decreased the endogenous VDR protein level in MCF‐7 cells to 40% of control. 1,25(OH)2 D 3 drastically induced the CYP24 mRNA level in MCF‐7 cells, but the induction was markedly attenuated by the overexpression of miR‐125b. In addition, the antiproliferative effects of 1,25(OH)2 D 3 in MCF‐7 cells were significantly abolished by the overexpression of miR‐125b. These results suggest that the endogenous VDR level was repressed by miR‐125b. In conclusion, we found that miR‐125b posttranscriptionally regulated human VDR. Since the miR‐125b level is known to be downregulated in cancer, such a decrease may result in the upregulation of VDR in cancer and augmentation of the antitumor effects of 1,25(OH)2 D 3. © 2009 UICC
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Holick, M. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmra070553 · Cited by 13,720
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
MicroRNA Gene Expression Deregulation in Human Breast Cancer
Iorio, M. V., Ferracin, M., Liu, C.-G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1783 · Cited by 4,053
Cited by
Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects
Christakos, S., Dhawan, P., Verstuyf, A., Verlinden, L., & Carmeliet, G. (2016) · Physiological Reviews · doi:10.1152/physrev.00014.2015 · Cited by 1,957
The role of vitamin D in reducing cancer risk and progression
Feldman, D., Krishnan, A. V., Swami, S., Giovannucci, E., & Feldman, B. J. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3691 · Cited by 1,311
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
Wang, Y., Zhang, S., Li, F., Zhou, Y., Zhang, Y., Wang, Z., Zhang, R., Zhu, J., Ren, Y., Tan, Y., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz981 · Cited by 794
Exploring vitamin D metabolism and function in cancer
Jeon, S.-M., & Shin, E.-A. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0038-9 · Cited by 550
Metadata
- Authors
- Mohri, T., Nakajima, M., Takagi, S., Komagata, S., & Yokoi, T.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2009-07-14
- Volume
- 125
- Issue
- 6
- Pages
- 1328-1333
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2052325097
- Cited by
- 209
- References
- 3
- FWCI
- 4.95
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.